Raggi A, Leonardi M, Arruda M, Caponnetto V, Castaldo M, Coppola G, Della PA, Fan X, Garcia-Azorin D, Gazerani P, Grangeon L, Grazzi L, Hsiao FJ, Ihara K, Labastida-Ramirez A, Lange KS, Lisicki M, Marcassoli A, Montisano DA, Onan D, Onofri A, Pellesi L, Peres M, Petrusic I, Raffaelli B, Rubio-Beltran E, Straube A, Straube S, Takizawa T, Tana C, Tinelli M, Valeriani M, Vigneri S, Vuralli D, Waliszewska-Prosol M, Wang W, Wang Y, Wells-Gatnik W, Wijeratne T, Martelletti P (2024) Hallmarks of primary headache: part 1 - migraine. J Headache Pain 25(1):189
Article PubMed PubMed Central Google Scholar
Dodick DW (2018) Migraine. Lancet 391(10127):1315–1330
Burch RC, Buse DC, Lipton RB (2019) Migraine: epidemiology, burden, and comorbidity. Neurol Clin 37(4):631–649
Agosti R (2018) Migraine burden of disease: from the patient’s experience to a socio-economic view. Headache 58 Suppl 1:17–32
Garcia-Azorin D, Moya-Alarcon C, Armada B, Sanchez DRM (2024) Societal and economic burden of migraine in Spain: results from the 2020 National health and wellness survey. J Headache Pain 25(1):38
Article PubMed PubMed Central Google Scholar
Mahmoud AN, Mentias A, Elgendy AY, Qazi A, Barakat AF, Saad M, Mohsen A, Abuzaid A, Mansoor H, Mojadidi MK, Elgendy IY (2018) Migraine and the risk of cardiovascular and cerebrovascular events: A meta-analysis of 16 cohort studies including 1152407 subjects. BMJ Open 8(3):e20498
Ng C, Tan B, Teo YN, Teo YH, Syn N, Leow A, Ho J, Chan MY, Wong R, Chai P, Chan A, Sharma VK, Yeo L, Sia CH, Ong J (2022) Myocardial infarction, stroke and cardiovascular mortality among migraine patients: A systematic review and meta-analysis. J Neurol 269(5):2346–2358
Burstein R, Noseda R, Borsook D (2015) Migraine: multiple processes, complex pathophysiology. J Neurosci 35(17):6619–6629
Article CAS PubMed PubMed Central Google Scholar
Assarzadegan F, Hosseinpanahi SP, Hesami O, Mansouri B, Lima BS (2019) Frequency of dyslipidemia in migraineurs in comparison to control group. J Family Med Prim Care 8(3):950–954
Article PubMed PubMed Central Google Scholar
Westgate C, Israelsen I, Jensen RH, Eftekhari S (2021) Understanding the link between obesity and headache-with focus on migraine and idiopathic intracranial hypertension. J Headache Pain 22(1):123
Article PubMed PubMed Central Google Scholar
Trabattoni D, Brambilla M, Canzano P, Becchetti A, Teruzzi G, Porro B, Fiorelli S, Muratori M, Tedesco CC, Veglia F, Montorsi P, Bartorelli AL, Tremoli E, Camera M (2022) Migraine in patients undergoing PFO closure: characterization of a platelet-associated pathophysiological mechanism: the LEARNER study. JACC Basic Transl Sci 7(6):525–540
Article PubMed PubMed Central Google Scholar
Frederiksen SD, Bekker-Nielsen DM, Snoer AH, Deen M, Edvinsson L (2020) Serotonin and neuropeptides in blood from episodic and chronic migraine and cluster headache patients in case-control and case-crossover settings: A systematic review and meta-analysis. Headache 60(6):1132–1164
Antonova M, Wienecke T, Olesen J, Ashina M (2013) Prostaglandins in migraine: update. Curr Opin Neurol 26(3):269–275
Article CAS PubMed Google Scholar
Bjork MH, Borkenhagen S, Oteiza F, Dueland AN, Sorgaard FE, Saether EM, Bugge C (2024) Comparative retention and effectiveness of migraine preventive treatments: A nationwide registry-based cohort study. Eur J Neurol 31(1):e16062
Makhlouf HA, Hassan AK, Almosilhy NA, Osman A, Ramadan S, Abouelmagd ME (2025) Exploring the association between Statins use or HMG-CoA reductase Inhibition and migraine: a systematic review and meta-analysis. J Headache Pain 26(1):23
Article CAS PubMed PubMed Central Google Scholar
Mangione CM, Barry MJ, Nicholson WK, Cabana M, Chelmow D, Coker TR, Davis EM, Donahue KE, Jaen CR, Kubik M, Li L, Ogedegbe G, Pbert L, Ruiz JM, Stevermer J, Wong JB (2022) Statin use for the primary prevention of cardiovascular disease in adults: US preventive services task force recommendation statement. JAMA 328(8):746–753
Sherafat A, Sahebnasagh A, Rahmany R, Mohammadi F, Saghafi F (2022) The preventive effect of the combination of Atorvastatin and Nortriptyline in migraine-type headache: a randomized, triple-blind, placebo-controlled trial. Neurol Res 44(4):311–317
Article CAS PubMed Google Scholar
Bi Y, Zhu Y, Tang S, Huang Y (2023) Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization study. J Headache Pain 24(1):112
Article CAS PubMed PubMed Central Google Scholar
Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, Kuder JF, Wang H, Liu T, Wasserman SM, Sever PS, Pedersen TR (2017) Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med 376(18):1713–1722
Article CAS PubMed Google Scholar
Mayyas F, Bani OE (2022) Plasma lipoprotein (a) and tissue plasminogen activator are associated with increased risk of atherosclerotic cardiovascular disease. Heliyon 8(7):e9836
Ren Y, Pan W, Li X, Wang S, Lv H, Yu Y, Wang M, Xia Y, Yin D (2022) The predictive value of Lp(a) for adverse cardiovascular event in ACS patients with an achieved LDL-C target at follow up after PCI. J Cardiovasc Transl Res 15(1):67–74
Hermans MP, Ahn SA, Rousseau MF (2012) The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females. Lipids Health Dis 11:132
Article CAS PubMed PubMed Central Google Scholar
Baba M, Maris M, Jianu D, Luca CT, Stoian D, Mozos I (2023) The impact of the blood lipids levels on arterial stiffness. J Cardiovasc Dev Dis 10(3):127
Maki KC, Guyton JR, Orringer CE, Hamilton-Craig I, Alexander DD, Davidson MH (2016) Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemia. J Clin Lipidol 10(4):905–914
Genest J, Frohlich J, Fodor G, McPherson R (2003) Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. CMAJ 169(9):921–924
PubMed PubMed Central Google Scholar
Kappelle PJ, Gansevoort RT, Hillege JL, Wolffenbuttel BH, Dullaart RP (2011) Apolipoprotein B/A-I and total cholesterol/high-density lipoprotein cholesterol ratios both predict cardiovascular events in the general population independently of nonlipid risk factors, albuminuria and C-reactive protein. J Intern Med 269(2):232–242
Article CAS PubMed Google Scholar
Zhou D, Liu X, Lo K, Huang Y, Feng Y (2022) The effect of total cholesterol/high-density lipoprotein cholesterol ratio on mortality risk in the general population. Front Endocrinol (Lausanne) 13:1012383
Hothorn T, Lausen B (2003) On the exact distribution of maximally selected rank statistics. Comput Stat Data an 43(2):121–137
Li D, Guo Y, Xia M, Zhang J, Zang W (2022) Dietary intake of thiamine and riboflavin in relation to severe headache or migraine: A cross-sectional survey. Headache 62(9):1133–1142
Evans EW, Lipton RB, Peterlin BL, Raynor HA, Thomas JG, O’Leary KC, Pavlovic J, Wing RR, Bond DS (2015) Dietary intake patterns and diet quality in a nationally representative sample of women with and without severe headache or migraine. Headache 55(4):550–561
Article PubMed PubMed Central Google Scholar
Chamberlain JJ, Rhinehart AS, Shaefer CJ, Neuman A (2016) Diagnosis and management of diabetes: synopsis of the 2016 American diabetes association standards of medical care in diabetes. Ann Intern Med 164(8):542–552
VanderWeele TJ, Ding P (2017) Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med 167(4):268–274
Xiao B, Cao C, Han Y, Yang F, Hu H, Luo J (2024) A non-linear connection between the total cholesterol to high-density lipoprotein cholesterol ratio and stroke risk: A retrospective cohort study from the China health and retirement longitudinal study. Eur J Med Res 29(1):175
Comments (0)